top of page

News & Updates

Filter by:

Lucence Announces Commercial Availability of Tissue500™ for Comprehensive Targeted Therapy Matching

News & Updates

14 Sept 2021

Lucence Announces Commercial Availability of Tissue500™ for Comprehensive Targeted Therapy Matching

Lucence Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board

News & Updates

2 Jun 2021

Lucence Presents Real-World Evidence on Applications of Liquid Biopsy at 2021 ASCO, Announces Formation of Medical Advisory Board

Lucence Launches US Validation Study for LiquidHALLMARK® Liquid Biopsy Test for Biomarker Detection in Lung Cancer

News & Updates

11 May 2021

Lucence Launches US Validation Study for LiquidHALLMARK® Liquid Biopsy Test for Biomarker Detection in Lung Cancer

Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening

News & Updates

24 Mar 2021

Lucence Partners with Waseda University to Develop an Integrated Liquid Biopsy Platform for Cancer Screening

Lucence Receives CLIA Certification for US Laboratory, Expands Access to Amplicon-Based Liquid Biopsy Tests

News & Updates

10 Dec 2020

Lucence Receives CLIA Certification for US Laboratory, Expands Access to Amplicon-Based Liquid Biopsy Tests

Lucence Shares Data at ASCO20 Demonstrating High Sensitivity of AmpliMARK™ Sequencing Technology in Detecting Clinically Relevant Biomarkers in Lung Cancer

News & Updates

26 May 2020

Lucence Shares Data at ASCO20 Demonstrating High Sensitivity of AmpliMARK™ Sequencing Technology in Detecting Clinically Relevant Biomarkers in Lung Cancer

Lucence Presents Data Demonstrating Potential of AmpliMARK™ Powered Sequencing to Detect Genomic Alterations at High Sensitivity in Blood Cancers

News & Updates

14 Jan 2020

Lucence Presents Data Demonstrating Potential of AmpliMARK™ Powered Sequencing to Detect Genomic Alterations at High Sensitivity in Blood Cancers

Lucence Raises USD $20M Series A Led by IHH Healthcare to Advance Liquid Biopsy for Early Detection of Multiple Cancers

News & Updates

20 Nov 2019

Lucence Raises USD $20M Series A Led by IHH Healthcare to Advance Liquid Biopsy for Early Detection of Multiple Cancers

1

/

4

bottom of page